FDA: 5 hospitals granted special permit to treat COVID-19 patients with ivermectin
(AFP)
MANILA, Philippines — Five hospitals in the country have so far been granted compassionate special permits (CSP) to use human-grade ivermectin to treat COVID-19 patients, the Food and Drug Administration (FDA) said Tuesday.
FDA Director-General Eric Domingo confirmed in a text message to 黑料社 that the number of hospitals given CSP for ivermectin has increased to five.
Only three hospitals had a CSP to use the drug for COVID-19 patients on April 22.
In an interview on ABS-CBN 黑料社 Channel, Domingo also disclosed that a company has expressed willingness to file for a certificate product registration (CPR) of imported ivermectin before the FDA.
He said representatives of the company, which he did not identify, have met with drug regulators in the country last week.
Article continues after this advertisementPrior to this development, local firm Lloyd Laboratories Inc. applied for a CPR of ivermectin for human use before the FDA.
gsg
For more news about the novel coronavirus click
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this
